Royal Philips announced a definitive agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging (EVI) of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. This strategic acquisition advances next-generation coronary intravascular imaging and physiological assessment for treating coronary artery disease.
SpectraWAVE’s key products include the HyperVue™ Imaging System, which combines DeepOCT and NIRS. The company also offers the X1™-FFR, an AI-enabled angio-based Fractional Flow Reserve solution. Philips will integrate both products into its existing Image-Guided Therapy portfolio, including its industry-leading Azurion platform. This integration aims to create a comprehensive offering to support better patient outcomes for complex coronary procedures.
The acquisition will expand Philips’ portfolio with breakthrough, AI-powered technologies. Roy Jakobs, CEO of Royal Philips, commented on the strategy:
“We are doubling down on image-guided therapy and expanding our portfolio in the coronary intervention segment with the addition of SpectraWAVE’s AI-powered innovations in high-definition intravascular imaging and angio-based physiological assessment, enabling us to deliver better care for more people.”
Eman Namati, PhD, CEO of SpectraWAVE, added:
“Philips shares our deep conviction that the convergence of intravascular imaging, coronary physiology and AI can fundamentally improve how every patient with coronary disease is treated. This partnership allows us to integrate and scale HyperVue and X1-FFR into the world’s leading image-guided therapy ecosystem, expanding choice for clinicians and supporting more consistent, high-quality care for the millions of patients who depend on coronary intervention each year.”
The acquisition will accelerate the adoption of advanced coronary intravascular imaging techniques by giving physicians a more streamlined workflow. It will also support better clinical decision-making.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: GlobeNewswire.com
